313 is the total number of securities Soleus Capital Management, L.P. has owned. The longest Soleus Capital Management, L.P. has owned a single stock is 16 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| EPIX | ESSA PHARMA INC | 16 | 16 | 0.65% | 4.79% | 10.84% | Q4 2019 | Q3 2023 | 16 |
| IRMD | IRADIMED CORP | 16 | 16 | 0.92% | 2.83% | 5.83% | Q4 2019 | Q3 2023 | 16 |
| XENE | XENON PHARMACEUTICALS INC | 13 | 2 | 0.16% | 1.00% | 2.94% | Q4 2019 | Q3 2023 | 15 |
| ISEE | IVERIC BIO INC | 14 | 14 | 1.37% | 3.98% | 6.50% | Q4 2019 | Q1 2023 | 14 |
| SRDX | SURMODICS INC | 14 | 14 | 0.53% | 2.67% | 4.65% | Q2 2020 | Q3 2023 | 14 |
| NTRA | NATERA INC | 9 | 1 | 0.25% | 1.47% | 3.87% | Q4 2019 | Q3 2023 | 13 |
| DXCM | DEXCOM INC | 7 | 1 | 0.26% | 1.24% | 4.22% | Q4 2019 | Q2 2023 | 13 |
| NVCR | NOVOCURE LTD | 10 | 3 | 0.14% | 1.03% | 3.38% | Q1 2020 | Q3 2023 | 13 |
| CRSP | CRISPR THERAPEUTICS AG | 7 | 1 | 0.13% | 0.68% | 2.57% | Q4 2019 | Q2 2023 | 13 |
| LYRA | LYRA THERAPEUTICS INC | 7 | 6 | 0.00% | 0.39% | 0.99% | Q2 2020 | Q3 2023 | 13 |
| BCAB | BIOATLA INC | 12 | 12 | 0.68% | 7.75% | 29.12% | Q4 2020 | Q3 2023 | 12 |
| CCCC | C4 THERAPEUTICS INC | 12 | 12 | 0.33% | 1.92% | 5.23% | Q4 2020 | Q3 2023 | 12 |
| KRYS | KRYSTAL BIOTECH INC | 12 | 12 | 0.08% | 1.49% | 2.48% | Q4 2020 | Q3 2023 | 12 |
| AXGN | AXOGEN INC | 5 | 2 | 0.08% | 1.04% | 2.20% | Q4 2019 | Q3 2023 | 12 |
| INSP | INSPIRE MED SYS INC | 10 | 1 | 0.24% | 1.00% | 2.54% | Q4 2019 | Q3 2023 | 12 |
| EDAP | EDAP TMS S A | 11 | 11 | 0.38% | 3.96% | 7.85% | Q1 2021 | Q3 2023 | 11 |
| PCVX | VAXCYTE INC | 11 | 11 | 0.70% | 1.59% | 3.17% | Q1 2021 | Q3 2023 | 11 |
| EIGR | EIGER BIOPHARMACEUTICA... | 8 | 3 | 0.22% | 1.33% | 3.39% | Q4 2019 | Q3 2022 | 11 |
| THTX | THERATECHNOLOGIES INC | 10 | 10 | 0.76% | 2.63% | 4.84% | Q1 2021 | Q2 2023 | 10 |
| NPCE | NEUROPACE INC | 10 | 10 | 0.51% | 2.21% | 5.06% | Q2 2021 | Q3 2023 | 10 |
| INBX | INHIBRX INC | 5 | 5 | 0.51% | 1.35% | 3.88% | Q3 2020 | Q3 2023 | 10 |
| CELC | CELCUITY INC | 10 | 10 | 0.04% | 1.04% | 2.43% | Q2 2021 | Q3 2023 | 10 |
| ENTA | ENANTA PHARMACEUTICALS... | 7 | 3 | 0.28% | 1.01% | 2.38% | Q1 2020 | Q1 2023 | 10 |
| PIRS | PIERIS PHARMACEUTICALS... | 7 | 3 | 0.15% | 0.58% | 1.62% | Q3 2020 | Q1 2023 | 10 |
| YMAB | Y-MABS THERAPEUTICS INC | 10 | 10 | 0.04% | 0.36% | 1.18% | Q2 2021 | Q3 2023 | 10 |
| UTHR | UNITED THERAPEUTICS CO... | 9 | 9 | 2.93% | 5.70% | 10.86% | Q3 2021 | Q3 2023 | 9 |
| ORGO | ORGANOGENESIS HLDGS INC | 9 | 9 | 1.42% | 2.84% | 4.33% | Q3 2021 | Q3 2023 | 9 |
| LNTH | LANTHEUS HLDGS INC | 8 | 1 | 0.57% | 2.80% | 5.10% | Q3 2020 | Q1 2023 | 9 |
| SKIN | THE BEAUTY HEALTH COMPANY | 7 | 2 | 0.50% | 2.41% | 6.57% | Q2 2021 | Q3 2023 | 9 |
| VCEL | VERICEL CORP | 5 | 4 | 0.28% | 2.12% | 3.76% | Q4 2019 | Q2 2023 | 9 |
| AZN | ASTRAZENECA PLC | 9 | 9 | 0.27% | 1.99% | 4.11% | Q2 2020 | Q2 2022 | 9 |
| CVS | CVS HEALTH CORP | 8 | 8 | 1.21% | 2.08% | 3.70% | Q4 2021 | Q3 2023 | 8 |
| DICE THERAPEUTICS INC | 8 | 8 | 0.41% | 1.77% | 4.49% | Q3 2021 | Q2 2023 | 8 | |
| ADVM | ADVERUM BIOTECHNOLOGIE... | 6 | 1 | 0.06% | 1.64% | 3.81% | Q4 2019 | Q2 2023 | 8 |
| ESTA | ESTABLISHMENT LABS HLD... | 3 | 2 | 0.33% | 0.81% | 2.50% | Q4 2019 | Q4 2022 | 8 |
| RFL | RAFAEL HLDGS INC | 8 | 8 | 0.10% | 0.63% | 1.33% | Q4 2019 | Q3 2021 | 8 |
| STAA | STAAR SURGICAL CO | 6 | 1 | 0.03% | 0.58% | 1.22% | Q4 2019 | Q4 2022 | 8 |
| FATE | FATE THERAPEUTICS INC | 4 | 1 | 0.05% | 0.40% | 1.03% | Q4 2019 | Q3 2022 | 8 |
| XILIO THERAPEUTICS INC | 8 | 8 | 0.04% | 0.23% | 0.76% | Q4 2021 | Q3 2023 | 8 | |
| ARCELLX INC | 7 | 7 | 1.79% | 3.15% | 4.90% | Q1 2022 | Q3 2023 | 7 | |
| HUM | HUMANA INC | 5 | 1 | 0.94% | 1.97% | 3.12% | Q4 2019 | Q3 2023 | 7 |
| MSON | MISONIX INC | 7 | 7 | 0.34% | 1.54% | 3.20% | Q4 2019 | Q2 2021 | 7 |
| CVRX | CVRX INC | 7 | 7 | 0.74% | 1.48% | 2.67% | Q2 2021 | Q4 2022 | 7 |
| ITMR | ITAMAR MED LTD | 7 | 7 | 0.37% | 1.27% | 1.92% | Q1 2020 | Q3 2021 | 7 |
| EOLS | EVOLUS INC | 5 | 2 | 0.76% | 1.25% | 1.98% | Q2 2021 | Q3 2023 | 7 |
| NARI | INARI MED INC | 4 | 1 | 0.09% | 0.97% | 2.05% | Q2 2020 | Q1 2023 | 7 |
| CUTR | CUTERA INC | 4 | 3 | 0.10% | 0.73% | 1.58% | Q1 2021 | Q4 2022 | 7 |
| KDMN | KADMON HLDGS INC | 7 | 7 | 0.05% | 0.61% | 1.53% | Q4 2019 | Q2 2021 | 7 |
| FDMT | 4D MOLECULAR THERAPEUT... | 4 | 3 | 0.14% | 0.54% | 0.84% | Q1 2021 | Q3 2023 | 7 |
| BRIDGEBIO PHARMA INC | 7 | 7 | 0.14% | 0.30% | 0.58% | Q1 2021 | Q3 2022 | 7 | |
| IMUX | IMMUNIC INC | 4 | 3 | 0.04% | 0.13% | 0.35% | Q4 2021 | Q3 2023 | 7 |
| ALXN | ALEXION PHARMACEUTICAL... | 6 | 6 | 0.39% | 2.40% | 4.99% | Q4 2019 | Q1 2021 | 6 |
| NRIX | NURIX THERAPEUTICS INC | 5 | 1 | 0.59% | 1.44% | 2.15% | Q3 2021 | Q3 2023 | 6 |
| ANGO | ANGIODYNAMICS INC | 4 | 2 | 0.24% | 1.40% | 2.85% | Q3 2021 | Q2 2023 | 6 |
| EXAS | EXACT SCIENCES CORP | 6 | 6 | 0.64% | 1.33% | 3.21% | Q2 2022 | Q3 2023 | 6 |
| BIIB | BIOGEN INC | 5 | 1 | 0.13% | 1.05% | 2.15% | Q4 2019 | Q3 2022 | 6 |
| CMPS | COMPASS PATHWAYS PLC | 5 | 1 | 0.27% | 0.91% | 2.90% | Q3 2020 | Q3 2023 | 6 |
| FGEN | FIBROGEN INC | 6 | 6 | 0.25% | 0.88% | 2.19% | Q4 2021 | Q1 2023 | 6 |
| GOSSAMER BIO INC | 6 | 6 | 0.33% | 0.78% | 1.32% | Q2 2020 | Q3 2021 | 6 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 3 | 3 | 0.30% | 0.56% | 0.98% | Q1 2022 | Q3 2023 | 6 |
| SNDX | SYNDAX PHARMACEUTICALS... | 4 | 2 | 0.16% | 0.43% | 0.80% | Q4 2019 | Q3 2023 | 6 |
| PCRX | PACIRA BIOSCIENCES INC | 3 | 3 | 0.22% | 0.40% | 0.61% | Q1 2020 | Q1 2022 | 6 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 4 | 1 | 0.05% | 0.38% | 1.52% | Q1 2021 | Q2 2023 | 6 |
| RVNC | REVANCE THERAPEUTICS INC | 6 | 6 | 0.12% | 0.30% | 0.55% | Q4 2019 | Q1 2021 | 6 |
| CRL | CHARLES RIV LABS INTL INC | 5 | 5 | 1.74% | 3.31% | 4.90% | Q3 2022 | Q3 2023 | 5 |
| ZYME | ZYMEWORKS INC | 5 | 5 | 0.14% | 2.91% | 8.65% | Q4 2019 | Q4 2020 | 5 |
| SNN | SMITH & NEPHEW PLC | 3 | 2 | 1.49% | 1.94% | 2.80% | Q4 2021 | Q3 2023 | 5 |
| TNDM | TANDEM DIABETES CARE INC | 4 | 1 | 0.44% | 1.54% | 2.70% | Q4 2019 | Q1 2023 | 5 |
| SIEN | SIENTRA INC | 5 | 5 | 0.47% | 1.12% | 2.13% | Q1 2021 | Q1 2022 | 5 |
| NEO | NEOGENOMICS INC | 4 | 1 | 0.33% | 1.06% | 2.44% | Q4 2020 | Q1 2022 | 5 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 3 | 2 | 0.52% | 1.00% | 1.33% | Q2 2022 | Q3 2023 | 5 |
| GLTO | GALECTO INC | 3 | 2 | 0.06% | 0.98% | 2.50% | Q4 2020 | Q3 2023 | 5 |
| TCRR | TCR2 THERAPEUTICS INC | 4 | 1 | 0.12% | 0.96% | 3.04% | Q1 2020 | Q2 2021 | 5 |
| BCYC | BICYCLE THERAPEUTICS PLC | 4 | 1 | 0.06% | 0.79% | 1.17% | Q4 2021 | Q3 2023 | 5 |
| NVRO | NEVRO CORP | 3 | 1 | 0.22% | 0.75% | 1.28% | Q4 2019 | Q3 2022 | 5 |
| KROS | KEROS THERAPEUTICS INC | 5 | 5 | 0.04% | 0.65% | 1.61% | Q3 2022 | Q3 2023 | 5 |
| TMDX | TRANSMEDICS GROUP INC | 5 | 5 | 0.15% | 0.63% | 0.99% | Q2 2022 | Q2 2023 | 5 |
| ETNB | 89BIO INC | 5 | 5 | 0.26% | 0.54% | 0.78% | Q3 2022 | Q3 2023 | 5 |
| ARYD | ARYA SCIENCES ACQU COR... | 5 | 5 | 0.30% | 0.44% | 0.57% | Q1 2021 | Q1 2022 | 5 |
| LUNG | PULMONX CORP | 3 | 2 | 0.06% | 0.26% | 0.58% | Q2 2021 | Q2 2023 | 5 |
| DA32 LIFE SCNCE TEC AC... | 5 | 5 | 0.07% | 0.23% | 0.54% | Q3 2021 | Q3 2022 | 5 | |
| HARP | HARPOON THERAPEUTICS INC | 4 | 4 | 0.29% | 2.19% | 6.34% | Q4 2019 | Q3 2020 | 4 |
| OSUR | ORASURE TECHNOLOGIES INC | 2 | 1 | 0.29% | 2.12% | 4.03% | Q2 2020 | Q3 2022 | 4 |
| ILMN | ILLUMINA INC | 2 | 1 | 0.70% | 2.10% | 3.93% | Q1 2022 | Q2 2023 | 4 |
| LLY | LILLY ELI & CO | 2 | 1 | 0.22% | 1.94% | 3.55% | Q2 2020 | Q2 2023 | 4 |
| APEN | APOLLO ENDOSURGERY INC | 4 | 4 | 0.85% | 1.73% | 2.26% | Q4 2021 | Q3 2022 | 4 |
| STE | STERIS PLC | 3 | 1 | 1.20% | 1.26% | 1.29% | Q4 2019 | Q2 2022 | 4 |
| TGTX | TG THERAPEUTICS INC | 4 | 4 | 0.40% | 1.25% | 2.22% | Q4 2022 | Q3 2023 | 4 |
| ABBV | ABBVIE INC | 2 | 1 | 0.30% | 1.16% | 2.35% | Q1 2020 | Q4 2021 | 4 |
| HZNP | HORIZON THERAPEUTICS P... | 3 | 1 | 0.12% | 1.04% | 2.15% | Q2 2020 | Q2 2022 | 4 |
| CNST | CONSTELLATION PHARMCET... | 4 | 4 | 0.12% | 0.81% | 1.91% | Q4 2019 | Q3 2020 | 4 |
| PODD | INSULET CORP | 2 | 1 | 0.38% | 0.79% | 1.88% | Q2 2020 | Q3 2023 | 4 |
| AXSM | AXSOME THERAPEUTICS INC | 4 | 4 | 0.13% | 0.60% | 1.53% | Q4 2022 | Q3 2023 | 4 |
| AMYLYX PHARMACEUTICALS... | 4 | 4 | 0.19% | 0.60% | 1.64% | Q3 2022 | Q2 2023 | 4 | |
| PHVS | PHARVARIS N V | 4 | 4 | 0.28% | 0.53% | 0.66% | Q4 2022 | Q3 2023 | 4 |
| CSTL | CASTLE BIOSCIENCES INC | 2 | 1 | 0.17% | 0.50% | 1.06% | Q2 2020 | Q3 2023 | 4 |
| DYN | DYNE THERAPEUTICS INC | 4 | 4 | 0.40% | 0.48% | 0.58% | Q1 2021 | Q4 2021 | 4 |
| ARNA | ARENA PHARMACEUTICALS INC | 2 | 1 | 0.37% | 0.46% | 0.53% | Q4 2019 | Q4 2021 | 4 |
| SBTX | SILVERBACK THERAPEUTIC... | 3 | 1 | 0.05% | 0.41% | 0.76% | Q4 2020 | Q3 2023 | 4 |
| IO BIOTECH INC | 4 | 4 | 0.11% | 0.37% | 0.48% | Q4 2021 | Q3 2022 | 4 | |
| KDNY | CHINOOK THERAPEUTICS INC | 3 | 1 | 0.21% | 0.31% | 0.49% | Q4 2021 | Q4 2022 | 4 |
| VSTM | VERASTEM INC | 4 | 4 | 0.19% | 0.28% | 0.34% | Q4 2021 | Q3 2022 | 4 |
| PLRX | PLIANT THERAPEUTICS INC | 3 | 1 | 0.06% | 0.24% | 0.61% | Q1 2022 | Q2 2023 | 4 |
| ALPN | ALPINE IMMUNE SCIENCES... | 2 | 2 | 0.07% | 0.22% | 0.60% | Q4 2020 | Q3 2023 | 4 |
| LQDA | LIQUIDIA CORPORATION | 2 | 2 | 0.10% | 0.16% | 0.27% | Q4 2021 | Q3 2023 | 4 |
| XBI | SPDR SER TR | 1 | 1 | 8.42% | 13.72% | 16.42% | Q1 2022 | Q3 2023 | 3 |
| AGLE | AEGLEA BIOTHERAPEUTICS... | 3 | 3 | 1.95% | 2.74% | 3.38% | Q4 2019 | Q2 2020 | 3 |
| ZYXI | ZYNEX INC | 3 | 3 | 1.09% | 2.70% | 4.49% | Q1 2020 | Q3 2020 | 3 |
| SIBN | SI-BONE INC | 3 | 3 | 1.26% | 1.77% | 2.16% | Q1 2023 | Q3 2023 | 3 |
| RIGL | RIGEL PHARMACEUTICALS INC | 3 | 3 | 1.48% | 1.75% | 2.03% | Q1 2023 | Q3 2023 | 3 |
| AXNX | AXONICS MODULATION TEC... | 3 | 3 | 0.98% | 1.43% | 1.86% | Q1 2020 | Q3 2020 | 3 |
| FOLD | AMICUS THERAPEUTICS INC | 3 | 3 | 0.77% | 1.21% | 1.77% | Q4 2019 | Q2 2020 | 3 |
| FLXN | FLEXION THERAPEUTICS INC | 1 | 1 | 0.70% | 1.17% | 1.98% | Q4 2019 | Q3 2021 | 3 |
| JASPER THERAPEUTICS INC | 3 | 3 | 0.54% | 1.04% | 1.40% | Q1 2023 | Q3 2023 | 3 | |
| HOWL | WEREWOLF THERAPEUTICS INC | 3 | 3 | 0.08% | 1.03% | 1.51% | Q2 2021 | Q4 2021 | 3 |
| CRDF | CARDIFF ONCOLOGY INC | 3 | 3 | 0.07% | 0.78% | 2.12% | Q3 2020 | Q1 2021 | 3 |
| ANAB | ANAPTYSBIO INC | 3 | 3 | 0.06% | 0.78% | 2.04% | Q2 2022 | Q4 2022 | 3 |
| NUVALENT INC | 3 | 3 | 0.64% | 0.76% | 1.00% | Q1 2023 | Q3 2023 | 3 | |
| ASMB | ASSEMBLY BIOSCIENCES INC | 3 | 3 | 0.61% | 0.74% | 0.93% | Q1 2021 | Q3 2021 | 3 |
| OSH | OAK STR HEALTH INC | 3 | 3 | 0.22% | 0.72% | 1.67% | Q3 2020 | Q1 2021 | 3 |
| MRK | MERCK & CO. INC | 3 | 3 | 0.31% | 0.63% | 1.17% | Q3 2020 | Q1 2021 | 3 |
| PRVB | PROVENTION BIO INC | 3 | 3 | 0.24% | 0.56% | 0.95% | Q2 2020 | Q4 2020 | 3 |
| INMD | INMODE LTD | 3 | 3 | 0.27% | 0.54% | 0.70% | Q1 2022 | Q3 2022 | 3 |
| ISRG | INTUITIVE SURGICAL INC | 2 | 1 | 0.30% | 0.52% | 0.89% | Q1 2022 | Q4 2022 | 3 |
| VKTX | VIKING THERAPEUTICS INC | 3 | 3 | 0.12% | 0.51% | 0.79% | Q1 2023 | Q3 2023 | 3 |
| ALKS | ALKERMES PLC | 3 | 3 | 0.14% | 0.50% | 0.68% | Q1 2023 | Q3 2023 | 3 |
| TVTX | TRAVERE THERAPEUTICS INC | 2 | 1 | 0.04% | 0.46% | 0.80% | Q3 2021 | Q2 2023 | 3 |
| VNDA | VANDA PHARMACEUTICALS INC | 2 | 1 | 0.23% | 0.43% | 0.80% | Q1 2020 | Q4 2021 | 3 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 2 | 1 | 0.06% | 0.42% | 0.73% | Q2 2022 | Q3 2023 | 3 |
| TRILLIUM THERAPEUTICS INC | 3 | 3 | 0.20% | 0.42% | 0.85% | Q3 2020 | Q1 2021 | 3 | |
| KRTX | KARUNA THERAPEUTICS INC | 3 | 3 | 0.10% | 0.36% | 0.64% | Q1 2023 | Q3 2023 | 3 |
| ACAD | ACADIA PHARMACEUTICALS... | 3 | 3 | 0.18% | 0.34% | 0.47% | Q1 2023 | Q3 2023 | 3 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3 | 3 | 0.08% | 0.26% | 0.59% | Q1 2021 | Q3 2021 | 3 |
| ANNX | ANNEXON INC | 3 | 3 | 0.11% | 0.24% | 0.36% | Q1 2023 | Q3 2023 | 3 |
| KYMR | KYMERA THERAPEUTICS INC | 3 | 3 | 0.11% | 0.19% | 0.26% | Q3 2020 | Q1 2021 | 3 |
| BEAM | BEAM THERAPEUTICS INC | 3 | 3 | 0.02% | 0.19% | 0.44% | Q2 2021 | Q4 2021 | 3 |
| ARVN | ARVINAS INC | 1 | 1 | 0.09% | 0.18% | 0.34% | Q4 2019 | Q4 2021 | 3 |
| PEPGEN INC | 3 | 3 | 0.02% | 0.15% | 0.27% | Q2 2022 | Q4 2022 | 3 | |
| INSMED INC | 3 | 3 | 0.10% | 0.13% | 0.18% | Q1 2020 | Q3 2020 | 3 | |
| XBI | SPDR SER TR | 1 | 1 | 14.48% | 33.48% | 52.48% | Q4 2020 | Q4 2021 | 2 |
| GRFS | GRIFOLS S A | 2 | 2 | 9.07% | 9.62% | 10.17% | Q4 2019 | Q1 2020 | 2 |
| TEVA | TEVA PHARMACEUTICAL IN... | 2 | 2 | 3.56% | 4.63% | 5.70% | Q2 2023 | Q3 2023 | 2 |
| AGN | ALLERGAN PLC | 2 | 2 | 3.01% | 4.13% | 5.26% | Q4 2019 | Q1 2020 | 2 |
| QDEL | QUIDEL CORP | 2 | 2 | 3.58% | 3.76% | 3.94% | Q2 2020 | Q3 2020 | 2 |
| SRPT | SAREPTA THERAPEUTICS INC | 2 | 2 | 3.15% | 3.30% | 3.44% | Q2 2020 | Q3 2020 | 2 |
| IMMU | IMMUNOMEDICS INC | 2 | 2 | 2.40% | 2.92% | 3.44% | Q2 2020 | Q3 2020 | 2 |
| MRSN | MERSANA THERAPEUTICS INC | 2 | 2 | 0.73% | 2.30% | 3.88% | Q3 2020 | Q4 2020 | 2 |
| BPMC | BLUEPRINT MEDICINES CORP | 1 | 1 | 1.00% | 1.52% | 2.04% | Q4 2019 | Q3 2020 | 2 |
| SGEN | SEAGEN INC | 2 | 2 | 1.49% | 1.50% | 1.52% | Q1 2023 | Q2 2023 | 2 |
| RETA | REATA PHARMACEUTICALS INC | 2 | 2 | 1.11% | 1.38% | 1.64% | Q1 2023 | Q2 2023 | 2 |
| ATRS | ANTARES PHARMA INC | 2 | 2 | 0.36% | 1.37% | 2.37% | Q1 2020 | Q2 2020 | 2 |
| TANGO THERAPEUTICS INC | 2 | 2 | 0.66% | 1.33% | 2.00% | Q2 2023 | Q3 2023 | 2 | |
| VSPR | VESPER HEALTHCARE ACQS... | 2 | 2 | 0.62% | 1.21% | 1.79% | Q4 2020 | Q1 2021 | 2 |
| SUPN | SUPERNUS PHARMACEUTICA... | 2 | 2 | 1.05% | 1.11% | 1.16% | Q1 2022 | Q2 2022 | 2 |
| BHC | BAUSCH HEALTH COS INC | 2 | 2 | 1.03% | 1.05% | 1.07% | Q2 2023 | Q3 2023 | 2 |
| ZFGN | ZAFGEN INC | 2 | 2 | 0.86% | 1.03% | 1.21% | Q4 2019 | Q1 2020 | 2 |
| IMVT | IMMUNOVANT INC | 2 | 2 | 0.37% | 0.89% | 1.42% | Q2 2023 | Q3 2023 | 2 |
| EXEL | EXELIXIS INC | 2 | 2 | 0.74% | 0.89% | 1.04% | Q4 2020 | Q1 2021 | 2 |
| IONS | IONIS PHARMACEUTICALS INC | 2 | 2 | 0.49% | 0.86% | 1.22% | Q2 2020 | Q3 2020 | 2 |
| CDNA | CAREDX INC | 2 | 2 | 0.41% | 0.83% | 1.25% | Q2 2021 | Q3 2021 | 2 |
| CTSO | CYTOSORBENTS CORP | 1 | 1 | 0.63% | 0.82% | 1.01% | Q1 2020 | Q3 2021 | 2 |
| PEN | PENUMBRA INC | 1 | 1 | 0.30% | 0.82% | 1.34% | Q2 2022 | Q4 2022 | 2 |
| MDXG | MIMEDX GROUP INC | 2 | 2 | 0.62% | 0.77% | 0.93% | Q1 2021 | Q2 2021 | 2 |
| GLPG | GALAPAGOS NV | 2 | 2 | 0.54% | 0.74% | 0.94% | Q3 2021 | Q4 2021 | 2 |
| MCRB | SERES THERAPEUTICS INC | 2 | 2 | 0.40% | 0.74% | 1.09% | Q2 2023 | Q3 2023 | 2 |
| VERASTEM INC | 2 | 2 | 0.43% | 0.72% | 1.01% | Q2 2023 | Q3 2023 | 2 | |
| RNA | AVIDITY BIOSCIENCES INC | 1 | 1 | 0.43% | 0.71% | 0.99% | Q1 2021 | Q4 2022 | 2 |
| TXG | 10X GENOMICS INC | 1 | 1 | 0.37% | 0.70% | 1.04% | Q1 2022 | Q4 2022 | 2 |
| DARIOHEALTH CORP | 2 | 2 | 0.62% | 0.69% | 0.76% | Q4 2020 | Q1 2021 | 2 | |
| ENOVIS CORPORATION | 2 | 2 | 0.64% | 0.68% | 0.73% | Q3 2022 | Q4 2022 | 2 | |
| BBIO | BRIDGEBIO PHARMA INC | 2 | 2 | 0.62% | 0.66% | 0.70% | Q1 2023 | Q2 2023 | 2 |
| PTCT | PTC THERAPEUTICS INC | 2 | 2 | 0.31% | 0.58% | 0.85% | Q4 2019 | Q1 2020 | 2 |
| RVMD | REVOLUTION MEDICINES INC | 2 | 2 | 0.47% | 0.54% | 0.61% | Q1 2021 | Q2 2021 | 2 |
| KNSA | KINIKSA PHARMACEUTICAL... | 2 | 2 | 0.25% | 0.53% | 0.81% | Q2 2023 | Q3 2023 | 2 |
| IMAGO BIOSCIENCES INC | 2 | 2 | 0.44% | 0.51% | 0.59% | Q3 2022 | Q4 2022 | 2 | |
| LVGO | LIVONGO HEALTH INC | 2 | 2 | 0.41% | 0.50% | 0.60% | Q4 2019 | Q1 2020 | 2 |
| EDIT | EDITAS MEDICINE INC | 2 | 2 | 0.15% | 0.49% | 0.83% | Q2 2021 | Q3 2021 | 2 |
| TARA | PROTARA THERAPEUTICS INC | 2 | 2 | 0.05% | 0.47% | 0.89% | Q3 2020 | Q4 2020 | 2 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 2 | 2 | 0.38% | 0.44% | 0.51% | Q2 2020 | Q3 2020 | 2 |
| CCXI | CHEMOCENTRYX INC | 1 | 1 | 0.25% | 0.42% | 0.60% | Q4 2021 | Q2 2022 | 2 |
| LRMR | LARIMAR THERAPEUTICS INC | 2 | 2 | 0.23% | 0.42% | 0.61% | Q2 2020 | Q3 2020 | 2 |
| BVS | BIOVENTUS INC | 2 | 2 | 0.21% | 0.42% | 0.62% | Q3 2021 | Q4 2021 | 2 |
| NSPR | INSPIREMD INC | 2 | 2 | 0.38% | 0.40% | 0.42% | Q2 2023 | Q3 2023 | 2 |
| RPTX | REPARE THERAPEUTICS INC | 2 | 2 | 0.04% | 0.39% | 0.74% | Q1 2021 | Q2 2021 | 2 |
| CARA | CARA THERAPEUTICS INC | 2 | 2 | 0.25% | 0.39% | 0.52% | Q4 2021 | Q1 2022 | 2 |
| RCKT | ROCKET PHARMACEUTICALS... | 2 | 2 | 0.06% | 0.37% | 0.68% | Q2 2022 | Q3 2022 | 2 |
| GENEDX HOLDINGS CORP | 2 | 2 | 0.26% | 0.37% | 0.47% | Q2 2023 | Q3 2023 | 2 | |
| GH | GUARDANT HEALTH INC | 1 | 1 | 0.33% | 0.35% | 0.37% | Q4 2019 | Q2 2021 | 2 |
| SWAV | SHOCKWAVE MED INC | 2 | 2 | 0.23% | 0.35% | 0.47% | Q4 2019 | Q1 2020 | 2 |
| ZGNX | ZOGENIX INC | 2 | 2 | 0.28% | 0.34% | 0.40% | Q3 2021 | Q4 2021 | 2 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.09% | 0.34% | 0.58% | Q2 2020 | Q4 2020 | 2 |
| AVDL | AVADEL PHARMACEUTICALS... | 2 | 2 | 0.10% | 0.33% | 0.56% | Q2 2023 | Q3 2023 | 2 |
| MDNA | MEDICENNA THERAPEUTICS... | 2 | 2 | 0.12% | 0.33% | 0.55% | Q3 2020 | Q4 2020 | 2 |
| CATABASIS PHARMACEUTIC... | 2 | 2 | 0.25% | 0.33% | 0.40% | Q1 2021 | Q2 2021 | 2 | |
| XERIS BIOPHARMA HOLDIN... | 2 | 2 | 0.05% | 0.32% | 0.60% | Q2 2023 | Q3 2023 | 2 | |
| RLMD | RELMADA THERAPEUTICS INC | 2 | 2 | 0.18% | 0.31% | 0.44% | Q1 2020 | Q2 2020 | 2 |
| RNLX | RENALYTIX PLC | 2 | 2 | 0.22% | 0.30% | 0.37% | Q1 2021 | Q2 2021 | 2 |
| MINERALYS THERAPEUTICS... | 2 | 2 | 0.15% | 0.29% | 0.44% | Q1 2023 | Q2 2023 | 2 | |
| CERE | CEREVEL THERAPEUTICS H... | 2 | 2 | 0.16% | 0.28% | 0.39% | Q1 2023 | Q2 2023 | 2 |
| PTGX | PROTAGONIST THERAPEUTI... | 1 | 1 | 0.12% | 0.25% | 0.37% | Q4 2022 | Q2 2023 | 2 |
| PARDES BIOSCIENCES INC | 2 | 2 | 0.17% | 0.24% | 0.30% | Q4 2022 | Q1 2023 | 2 | |
| PRAX | PRAXIS PRECISION MEDIC... | 2 | 2 | 0.18% | 0.22% | 0.27% | Q2 2023 | Q3 2023 | 2 |
| ONCR | ONCORUS INC | 2 | 2 | 0.17% | 0.20% | 0.24% | Q4 2020 | Q1 2021 | 2 |
| VENTYX BIOSCIENCES INC | 1 | 1 | 0.08% | 0.20% | 0.32% | Q4 2022 | Q2 2023 | 2 | |
| AADI BIOSCIENCE INC | 2 | 2 | 0.15% | 0.20% | 0.25% | Q2 2023 | Q3 2023 | 2 | |
| TPTX | TURNING POINT THERAPEU... | 2 | 2 | 0.10% | 0.20% | 0.31% | Q4 2020 | Q1 2021 | 2 |
| SRRK | SCHOLAR ROCK HLDG CORP | 2 | 2 | 0.16% | 0.20% | 0.24% | Q4 2020 | Q1 2021 | 2 |
| ACRS | ACLARIS THERAPEUTICS INC | 2 | 2 | 0.17% | 0.19% | 0.21% | Q1 2023 | Q2 2023 | 2 |
| PARAGON 28 INC | 2 | 2 | 0.02% | 0.19% | 0.36% | Q1 2023 | Q2 2023 | 2 | |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.05% | 0.18% | 0.30% | Q1 2022 | Q2 2023 | 2 |
| GLUE | MONTE ROSA THERAPEUTIC... | 2 | 2 | 0.09% | 0.17% | 0.26% | Q2 2021 | Q3 2021 | 2 |
| MGTA | MAGENTA THERAPEUTICS INC | 2 | 2 | 0.14% | 0.17% | 0.21% | Q1 2021 | Q2 2021 | 2 |
| MRTX | MIRATI THERAPEUTICS INC | 2 | 2 | 0.11% | 0.17% | 0.23% | Q4 2020 | Q1 2021 | 2 |
| MORF | MORPHIC HLDG INC | 1 | 1 | 0.09% | 0.17% | 0.24% | Q1 2021 | Q2 2023 | 2 |
| RCEL | AVITA MEDICAL INC | 2 | 2 | 0.10% | 0.12% | 0.14% | Q2 2023 | Q3 2023 | 2 |
| NGM | NGM BIOPHARMACEUTICALS... | 2 | 2 | 0.02% | 0.08% | 0.13% | Q3 2021 | Q4 2021 | 2 |
| IWM | ISHARES TR | 1 | 1 | 11.32% | 11.32% | 11.32% | Q4 2021 | Q4 2021 | 1 |
| ZYME | ZYMEWORKS INC | 1 | 1 | 6.74% | 6.74% | 6.74% | Q2 2020 | Q2 2020 | 1 |
| WMGI | WRIGHT MED GROUP N V | 1 | 1 | 6.66% | 6.66% | 6.66% | Q4 2019 | Q4 2019 | 1 |
| PRTA | PROTHENA CORP PLC | 1 | 1 | 4.02% | 4.02% | 4.02% | Q2 2020 | Q2 2020 | 1 |
| GSK PLC | 1 | 1 | 3.15% | 3.15% | 3.15% | Q3 2023 | Q3 2023 | 1 | |
| SKIN | THE BEAUTY HEALTH COMPANY | 1 | 1 | 2.61% | 2.61% | 2.61% | Q2 2022 | Q2 2022 | 1 |
| DERM | DERMIRA INC | 1 | 1 | 2.41% | 2.41% | 2.41% | Q4 2019 | Q4 2019 | 1 |
| TMCI | TREACE MED CONCEPTS INC | 1 | 1 | 2.31% | 2.31% | 2.31% | Q3 2023 | Q3 2023 | 1 |
| UNH | UNITEDHEALTH GROUP INC | 1 | 1 | 2.29% | 2.29% | 2.29% | Q1 2020 | Q1 2020 | 1 |
| HOLX | HOLOGIC INC | 1 | 1 | 2.24% | 2.24% | 2.24% | Q1 2022 | Q1 2022 | 1 |
| NVST | ENVISTA HOLDINGS CORPO... | 1 | 1 | 2.14% | 2.14% | 2.14% | Q3 2022 | Q3 2022 | 1 |
| NVTA | INVITAE CORP | 1 | 1 | 1.35% | 1.35% | 1.35% | Q4 2020 | Q4 2020 | 1 |
| ATRC | ATRICURE INC | 1 | 1 | 1.24% | 1.24% | 1.24% | Q3 2023 | Q3 2023 | 1 |
| HCA | HCA HEALTHCARE INC | 1 | 1 | 1.19% | 1.19% | 1.19% | Q4 2022 | Q4 2022 | 1 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1 | 1 | 1.15% | 1.15% | 1.15% | Q3 2023 | Q3 2023 | 1 |
| IONIS PHARMACEUTICALS INC | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2020 | Q4 2020 | 1 | |
| BNTX | BIONTECH SE | 1 | 1 | 0.98% | 0.98% | 0.98% | Q3 2023 | Q3 2023 | 1 |
| INCY | INCYTE CORP | 1 | 1 | 0.94% | 0.94% | 0.94% | Q2 2022 | Q2 2022 | 1 |
| RAYZEBIO INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q3 2023 | Q3 2023 | 1 | |
| AVTE | AEROVATE THERAPEUTICS INC | 1 | 1 | 0.91% | 0.91% | 0.91% | Q4 2022 | Q4 2022 | 1 |
| MLND | MILLENDO THERAPEUTICS INC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q1 2020 | Q1 2020 | 1 |
| SOLENO THERAPEUTICS INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2023 | Q3 2023 | 1 | |
| OFIX | ORTHOFIX MED INC | 1 | 1 | 0.87% | 0.87% | 0.87% | Q4 2022 | Q4 2022 | 1 |
| ZEAL | ZEALAND PHARMA A S | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2019 | Q4 2019 | 1 |
| MRUS | MERUS N V | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2023 | Q3 2023 | 1 |
| SOMALOGIC INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q3 2021 | Q3 2021 | 1 | |
| ICAD | ICAD INC | 1 | 1 | 0.71% | 0.71% | 0.71% | Q4 2019 | Q4 2019 | 1 |
| GENEDX HOLDINGS CORP | 1 | 1 | 0.68% | 0.68% | 0.68% | Q1 2023 | Q1 2023 | 1 | |
| SILK | SILK RD MED INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q2 2020 | Q2 2020 | 1 |
| AVIR | ATEA PHARMACEUTICALS INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q3 2021 | Q3 2021 | 1 |
| PHG | KONINKLIJKE PHILIPS N V | 1 | 1 | 0.63% | 0.63% | 0.63% | Q1 2021 | Q1 2021 | 1 |
| KNTE | KINNATE BIOPHARMA INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2021 | Q1 2021 | 1 |
| BLFS | BIOLIFE SOLUTIONS INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2023 | Q3 2023 | 1 |
| BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.56% | 0.56% | 0.56% | Q2 2023 | Q2 2023 | 1 |
| OAC | OAKTREE ACQUISITION CORP | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2020 | Q4 2020 | 1 |
| BLI | BERKELEY LTS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q4 2022 | Q4 2022 | 1 |
| INSM | INSMED INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q3 2023 | Q3 2023 | 1 |
| VAPO | VAPOTHERM INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q2 2020 | Q2 2020 | 1 |
| RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2022 | Q4 2022 | 1 |
| VIVO | MERIDIAN BIOSCIENCE INC | 1 | 1 | 0.49% | 0.49% | 0.49% | Q3 2021 | Q3 2021 | 1 |
| URGN | UROGEN PHARMA LTD | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2023 | Q3 2023 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2021 | Q3 2021 | 1 |
| THERATECHNOLOGIES INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2023 | Q3 2023 | 1 | |
| CDMO | AVID BIOSERVICES INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2021 | Q3 2021 | 1 |
| CBAY | CYMABAY THERAPEUTICS INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2023 | Q2 2023 | 1 |
| MASI | MASIMO CORP | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2020 | Q2 2020 | 1 |
| BAX | BAXTER INTL INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2021 | Q4 2021 | 1 |
| AMRN | AMARIN CORP PLC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2020 | Q1 2020 | 1 |
| TKNO | ALPHA TEKNOVA INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2021 | Q2 2021 | 1 |
| TARS | TARSUS PHARMACEUTICALS... | 1 | 1 | 0.41% | 0.41% | 0.41% | Q3 2023 | Q3 2023 | 1 |
| ABCM | ABCAM PLC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2023 | Q1 2023 | 1 |
| ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2019 | Q4 2019 | 1 |
| TWST | TWIST BIOSCIENCE CORP | 1 | 1 | 0.36% | 0.36% | 0.36% | Q2 2023 | Q2 2023 | 1 |
| KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2022 | Q2 2022 | 1 |
| NEOG | NEOGEN CORP | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2022 | Q4 2022 | 1 |
| HALO | HALOZYME THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2021 | Q2 2021 | 1 |
| OCX | ONCOCYTE CORP | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2021 | Q1 2021 | 1 |
| APLT | APPLIED THERAPEUTICS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2023 | Q3 2023 | 1 |
| BIOHAVEN LTD | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2023 | Q3 2023 | 1 | |
| DFHT | DEERFIELD HEALTHCARE T... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2021 | Q1 2021 | 1 |
| ADRO | ADURO BIOTECH INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2020 | Q1 2020 | 1 |
| RAPT | RAPT THERAPEUTICS INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2020 | Q2 2020 | 1 |
| CYTEK BIOSCIENCES INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2022 | Q1 2022 | 1 | |
| BDTX | BLACK DIAMOND THERAPEU... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2023 | Q2 2023 | 1 |
| AYTU | AYTU BIOSCIENCE INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2020 | Q1 2020 | 1 |
| CMAX | CAREMAX INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2021 | Q2 2021 | 1 |
| ARGX | ARGENX SE | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2019 | Q4 2019 | 1 |
| DRNA | DICERNA PHARMACEUTICAL... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2019 | Q4 2019 | 1 |
| DSGN | DESIGN THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2023 | Q3 2023 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2021 | Q3 2021 | 1 |
| CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2023 | Q1 2023 | 1 |
| NVO | NOVO-NORDISK A S | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2022 | Q3 2022 | 1 |
| CGEM | CULLINAN ONCOLOGY INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2022 | Q2 2022 | 1 |
| MGEN | MIRAGEN THERAPEUTICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
| OM | OUTSET MED INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2022 | Q2 2022 | 1 |
| ASTRIA THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2021 | Q3 2021 | 1 | |
| IRTC | IRHYTHM TECHNOLOGIES INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2020 | Q3 2020 | 1 |
| RXSIGHT INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2023 | Q1 2023 | 1 | |
| AVALO THERAPEUTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2021 | Q4 2021 | 1 | |
| APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 |
| ORCHESTRA BIOMED HLDGS... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2023 | Q1 2023 | 1 | |
| OLK | OLINK HLDG AB | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2022 | Q1 2022 | 1 |
| AFMD | AFFIMED N V | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2020 | Q3 2020 | 1 |
| PROCEPT BIOROBOTICS CORP | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 | |
| VTGN | VISTAGEN THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2022 | Q2 2022 | 1 |
| IMCR | IMMUNOCORE HLDGS PLC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2023 | Q2 2023 | 1 |
| HIMSWS | HIMS & HERS HEALTH INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
| RYTM | RHYTHM PHARMACEUTICALS... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2023 | Q2 2023 | 1 |
| APOGEE THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2023 | Q3 2023 | 1 | |
| UMRX | UNUM THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2020 | Q3 2020 | 1 |
| DCTH | DELCATH SYS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2023 | Q3 2023 | 1 |
| VRNA | VERONA PHARMA PLC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2023 | Q2 2023 | 1 |
| INDIVIOR PLC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2023 | Q2 2023 | 1 | |
| OACWS | OAKTREE ACQUISITION CORP | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2020 | Q4 2020 | 1 |
| KIDS | ORTHOPEDIATRICS CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q4 2022 | 1 |
| MDXHEALTH SA | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2023 | Q1 2023 | 1 | |
| STRO | SUTRO BIOPHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 |
Download | |||||||||
The securities at the top of the list , including ESSA PHARMA INC, IRADIMED CORP, and XENON PHARMACEUTICALS INC, are the highest-conviction holdings of Soleus Capital Management, L.P..
The conviction is calculated by counting the number of quarters a security has been reported by Soleus Capital Management, L.P.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Soleus Capital Management, L.P. owns currently or has owned in the past.